The stock of Motif Bio PLC (LON:MTFB) hit a new 52-week low and has GBX 28.80 target or 10.00% below today’s GBX 32.00 share price. The 5 months bearish chart indicates high risk for the GBX 34.62M company. The 1-year low was reported on Nov, 17 by Barchart.com. If the GBX 28.80 price target is reached, the company will be worth GBX 3.46 million less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. The stock decreased 3.03% or GBX 1 on November 17, hitting GBX 32. About 1.13 million shares traded hands or 528.36% up from the average. Motif Bio PLC (LON:MTFB) has declined 25.93% since April 19, 2016 and is downtrending. It has underperformed by 30.55% the S&P500.
Motif Bio PLC (LON:MTFB) Ratings Coverage
Out of 2 analysts covering Motif Bio Plc (LON:MTFB), 1 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 50% are positive. GBX 140 is the highest target while GBX 110 is the lowest. The GBX 125 average target is 290.63% above today’s (GBX 32) stock price. Motif Bio Plc has been the topic of 40 analyst reports since July 23, 2015 according to StockzIntelligence Inc. Northland Capital maintained Motif Bio PLC (LON:MTFB) on Thursday, July 23 with “Buy” rating. The stock has “Buy” rating given by Northland Capital on Wednesday, July 27. Northland Capital maintained the shares of MTFB in a report on Tuesday, December 15 with “Buy” rating. The rating was maintained by Northland Capital with “Buy” on Friday, August 26. Beaufort Securities maintained the stock with “Speculative Buy” rating in Tuesday, August 25 report. The company was maintained on Tuesday, August 9 by Northland Capital. The firm has “Buy” rating by Northland Capital given on Monday, March 14. The company was maintained on Tuesday, November 24 by Northland Capital. The stock of Motif Bio PLC (LON:MTFB) has “Buy” rating given on Wednesday, March 23 by Northland Capital. As per Tuesday, October 13, the company rating was maintained by Northland Capital.
Another recent and important Motif Bio PLC (LON:MTFB) news was published by Uk.Finance.Yahoo.com which published an article titled: “Motif Bio Plc (MTFB.L)” on April 02, 2015.
Motif Bio plc is a clinical-stage biopharmaceutical company. The company has a market cap of 34.62 million GBP. The Firm is engaged in development of antibiotics, which are designed for treatment of infections caused by multi-drug resistant bacteria. It currently has negative earnings. It operates in the development and commercialization of pharmaceutical formulations segment.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.